GIS:FRA
Gilead Sciences, Inc
€132,92
arrow_upward
+0,05%(+0,060) 1D
1 Okt., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€131,24
High
€132,92
Low
€131,24
Mkt. cap
182,89 mjd
Avg. vol.
439,00
Volume
30,00
52-wk high
€134,58
52-wk low
€93,70
No. of employees
17 k
Open
€131,24
High
€132,92
Low
€131,24
Mkt. cap
182,89 mjd
Avg. vol.
439,00
Volume
30,00
52-wk high
€134,58
52-wk low
€93,70
No. of employees
17 k
News stories
From web sources and news partners
MarketBeat
·
4 uur gelede
Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD
AD HOC NEWS
·
4 uur gelede
Gilead Sciences stock after-hours at EUR 131.85: plus 0.62 percent after the Xetra close
Barron's
·
7 uur gelede
More Upside Awaits for Gilead Sciences Stock. Stay Invested.
Yahoo Finance
·
9 uur gelede
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEODaniel O'Day
Employees17 k
Founded22 Jun. 1987
HeadquartersFoster City, Kalifornië, Verenigde State van Amerika
Sector-
Websitegilead.com